Equifax [EFX] vs Icf International [ICFI] Detailed Stock Comparison
Equifax
NYSE
Loading...
Icf International
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Equifax wins in 9 metrics, Icf International wins in 11 metrics, with 0 ties. Icf International appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Equifax | Icf International | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 46.75 | 16.52 | Icf International |
| Price-to-Book Ratio | 5.82 | 1.75 | Icf International |
| Debt-to-Equity Ratio | 93.55 | 64.70 | Icf International |
| PEG Ratio | 25.48 | 11.77 | Icf International |
| EV/EBITDA | 18.98 | 10.84 | Icf International |
| Profit Margin (TTM) | 10.95% | 5.45% | Equifax |
| Operating Margin (TTM) | 20.22% | 8.40% | Equifax |
| EBITDA Margin (TTM) | 20.22% | 8.40% | Equifax |
| Return on Equity | 12.76% | 11.09% | Equifax |
| Return on Assets (TTM) | 5.80% | 5.04% | Equifax |
| Free Cash Flow (TTM) | $813.00M | $150.11M | Equifax |
| Dividend Yield | 0.46% | 0.78% | Icf International |
| 1-Year Return | -13.87% | -39.19% | Equifax |
| Price-to-Sales Ratio (TTM) | 5.06 | 0.88 | Icf International |
| Enterprise Value | $34.53B | $2.39B | Equifax |
| EV/Revenue Ratio | 5.91 | 1.21 | Icf International |
| Gross Profit Margin (TTM) | 56.76% | 37.33% | Equifax |
| Revenue per Share (TTM) | $47 | $106 | Icf International |
| Earnings per Share (Diluted) | $5.13 | $5.74 | Icf International |
| Beta (Stock Volatility) | 1.64 | 0.49 | Icf International |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Equifax vs Icf International Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Equifax | -0.87% | -0.08% | -9.22% | -11.56% | -5.18% | -4.51% |
| Icf International | 2.79% | 7.22% | 6.97% | 8.46% | -17.53% | -19.57% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Equifax | -13.87% | 7.86% | 45.57% | 129.53% | 694.07% | 603.46% |
| Icf International | -39.19% | -9.04% | 32.59% | 168.44% | 323.77% | 649.72% |
Performance & Financial Health Analysis: Equifax vs Icf International
| Metric | EFX | ICFI |
|---|---|---|
| Market Information | ||
| Market Cap | $29.54B | $1.75B |
| Market Cap Category | Large cap | Small cap |
| 10 Day Avg. Volume | 1,042,150 | 256,120 |
| 90 Day Avg. Volume | 1,099,837 | 196,767 |
| Last Close | $239.81 | $94.84 |
| 52 Week Range | $199.98 - $309.63 | $75.91 - $179.67 |
| % from 52W High | -22.55% | -47.21% |
| All-Time High | $309.63 (Sep 16, 2024) | $179.67 (Nov 04, 2024) |
| % from All-Time High | -22.55% | -47.21% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | -0.07% |
| Quarterly Earnings Growth | 0.17% | -0.08% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.05% |
| Operating Margin (TTM) | 0.20% | 0.08% |
| Return on Equity (TTM) | 0.13% | 0.11% |
| Debt to Equity (MRQ) | 93.55 | 64.70 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $41.22 | $54.29 |
| Cash per Share (MRQ) | $1.53 | $0.39 |
| Operating Cash Flow (TTM) | $1.39B | $139.83M |
| Levered Free Cash Flow (TTM) | $864.12M | $113.17M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.46% | 0.78% |
| Last 12-Month Dividend | $1.17 | $0.70 |
Valuation & Enterprise Metrics Analysis: Equifax vs Icf International
| Metric | EFX | ICFI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 46.75 | 16.52 |
| Forward P/E | 25.48 | 11.77 |
| PEG Ratio | 25.48 | 11.77 |
| Price to Sales (TTM) | 5.06 | 0.88 |
| Price to Book (MRQ) | 5.82 | 1.75 |
| Market Capitalization | ||
| Market Capitalization | $29.54B | $1.75B |
| Enterprise Value | $34.53B | $2.39B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.91 | 1.21 |
| Enterprise to EBITDA | 18.98 | 10.84 |
| Risk & Other Metrics | ||
| Beta | 1.64 | 0.49 |
| Book Value per Share (MRQ) | $41.22 | $54.29 |
Financial Statements Comparison: Equifax vs Icf International
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EFX | ICFI |
|---|---|---|
| Revenue/Sales | $1.44B | $476.16M |
| Cost of Goods Sold | $656.70M | $298.43M |
| Gross Profit | $785.30M | $177.73M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $235.80M | $40.01M |
| EBITDA | $414.70M | $53.07M |
| Pre-Tax Income | $185.40M | $29.95M |
| Income Tax | $51.60M | $6.29M |
| Net Income (Profit) | $133.80M | $23.66M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EFX | ICFI |
|---|---|---|
| Cash & Equivalents | $195.20M | $5.72M |
| Total Current Assets | $1.48B | $510.83M |
| Total Current Liabilities | $1.73B | $381.53M |
| Long-Term Debt | $4.32B | $664.77M |
| Total Shareholders Equity | $5.11B | $968.87M |
| Retained Earnings | $6.10B | $899.05M |
| Property, Plant & Equipment | $285.10M | $176.52M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EFX | ICFI |
|---|---|---|
| Operating Cash Flow | $223.90M | $-3.31M |
| Capital Expenditures | N/A | $-3.45M |
| Free Cash Flow | $116.70M | $-36.49M |
| Debt Repayment | $-48.10M | $-431.58M |
| Common Stock Repurchase | N/A | $-39.34M |
Short Interest & Institutional Ownership Analysis
| Metric | EFX | ICFI |
|---|---|---|
| Shares Short | 2.42M | 466,400 |
| Short Ratio | 2.45 | 2.83 |
| Short % of Float | 0.02% | 0.03% |
| Average Daily Volume (10 Day) | 1,042,150 | 256,120 |
| Average Daily Volume (90 Day) | 1,099,837 | 196,767 |
| Shares Outstanding | 123.95M | 18.67M |
| Float Shares | 123.19M | 18.14M |
| % Held by Insiders | 0.01% | 0.02% |
| % Held by Institutions | 1.01% | 0.98% |
Dividend Analysis & Yield Comparison: Equifax vs Icf International
| Metric | EFX | ICFI |
|---|---|---|
| Last 12-Month Dividend | $1.17 | $0.70 |
| Last 12-Month Dividend Yield | 0.46% | 0.78% |
| 3-Year Avg Annual Dividend | $1.30 | $0.61 |
| 3-Year Avg Dividend Yield | 0.17% | 0.12% |
| 3-Year Total Dividends | $3.90 | $1.82 |
| Ex-Dividend Date | Feb 21, 2025 | Sep 05, 2025 |